Nicholas Sells, MD
Infectious Disease · New York, NYNPI 1225266349
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $112 of the $142 with a category attached, or 79.2%. 8 manufacturers reported payments, led by Getinge USA Sales, LLC at 29.3% of the total. Reporting peaked in 2020 at $82 and has fallen 66.0% since, to $28 in 2021. That places this record below the midpoint for infectious disease clinicians in NY, where the typical reported total is $190.
Across 8 payments — averaging $17.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Getinge USA Sales, LLC$42
- Insmed, Inc.$16
- Johnson & Johnson$16
- Merck$16
- Astellas Pharma US Inc$15
- Napo Pharmaceuticals Inc$13
- plus $24 from 2 others
What the payments were for
- Speaking & faculty fees$139%
- Food & beverage$11279%
- Education$1611%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Getinge USA Sales, LLC | 1 | $42 |
| Insmed, Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $16 |
| Merck | 1 | $16 |
| Astellas Pharma US Inc | 1 | $15 |
| Napo Pharmaceuticals Inc | 1 | $13 |
| Viiv Healthcare Company | 1 | $12 |
| Ultragenyx Pharmaceutical Inc. | 1 | $12 |
How this compares
$142 in reported general payments places this provider in the 45th percentile of 799 infectious disease providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other infectious disease in New York
- Sian JonesNew York$406K
- Antonio UrbinaNew York$373K
- David BekhorNew York$358K
- Genovefa PapanicolaouNew York$209K
- Michelle CespedesNew York$125K
- Donald KaminskyNew York$120K
- Judith AbergNew York$104K
- Thomas WalshNew York$98K
- Stuart HaberNew York$73K
- Michael GaisaNew York$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.